-
Insulin lispro, sold
under the
brand name
Humalog among others, is a
modified type of
medical insulin used to
treat type 1 and type 2 diabetes. It is...
- (olanzapine) (1996). The company's
primary revenue drivers are the
diabetes drugs Humalog (insulin lispro) (1996) and
Trulicity (dulaglutide) (2014).
Lilly was the...
-
analog was
developed for
clinical use at
mealtime (prandial insulin),
Humalog (insulin lispro), it is more
rapidly absorbed after subcutaneous injection...
- ISSN 1753-0393. PMID 30264527. "
Humalog-
insulin lispro injection,
solution Humalog Kwikpen-
insulin lispro injection,
solution Humalog Junior Kwikpen- insulin...
- the
development of some of the
first rDNA-derived medicines,
including Humalog and Forteo. The
following year, he was
elected as
member of the National...
- rapid-acting
insulins (peak at ~1 hour) are:[citation needed]
Insulin lispro (
Humalog)
Insulin aspart (Novolog)
Insulin glulisine (Apidra)
Examples of short-acting...
-
These insulins are
absorbed more
quickly than the
currently available Humalog, Novolog, and
Apidra which have a peak at
about 60 minutes.
Faster insulin...
-
homosalate (INN)
homprenorphine (INN)
hopantenic acid (INN)
hoquizil (INN)
Humalog (Eli
Lilly and Company)
HumaSPECT (PerImmune, Inc.)
Humatin (Pfizer) Humatrope...
- [citation needed] Rapid-acting
insulin analogs such as
lispro (brand name
Humalog, made by Eli
Lilly and Company) and
aspart (brand name Novolog/Novorapid...
-
Archived from the
original on
February 15, 2022.
Retrieved April 4, 2022. "
Humalog EPAR".
European Medicines Agency (EMA).
September 12, 2006.
Archived from...
